PROGRAM OVERVIEW

Join the National Lipid Association in South Florida, May 16-19, 2019, at the Turnberry Isle Miami for the lipidology event of the year!

Experience cutting-edge presentations from world-class faculty, network with other healthcare professionals, check out stimulating research in Poster Hall, and experience all of the flair that Miami has to offer!

Key topics include:

  • Key Messages from the 2019 ACC/AHA Cardiovascular Disease Prevention Guidelines
  • South Asians and Risk for ASCVD
  • What Do We Know About Low LDL?
  • Role of Genetic Testing in Clinical Lipidology and CV Prevention – A Primer for the Busy Clinician

Download the PDF

You may need to disable administrative overlay in your Drupal record

Edit Parent - SPECIAL EVENTS (visibility Show)

Foundation Event



Join the Foundation of the National Lipid Association (NLA) for our annual fundraiser Gala during the NLA’s 2019 Scientific Sessions. We are looking forward to hosting you in Aventura for an evening of dinner, cocktails, live music, dancing, prizes, and comradery. Your presence and dedication to the Foundation will be in support of our work in 2019 and beyond, including health screenings in underserved populations, resources for rare disease patients, health awareness campaigns, and much more. We have also partnered with the Miami Rescue Mission to demonstrate care for our host community. The Foundation will provide heart-healthy eating-on-a-budget informational flyers for the homeless Miami citizens served by the Rescue Mission programs, but they need your help too! Bring any of the following donation items to the Gala and be entered into a prize raffle. We look forward to seeing you soon!

a. Deodorant (for both men and women)
b. Shaving Cream
c. Razors
d. Anti-Bacterial soap
e. Bars of soap
f. Men’s clothing
 
Sponsored by Aegerion Pharmaceuticals

Symposia


Wednesday, May 15 • 6:30 - 8:00pm

Location: Royal Ballroom 2

What is New in LDL-Apheresis Indications/Treatments

This dynamic one-hour program will discuss what is new in LDL Apheresis. Three lipid experts will explore the topics of New FDA Indication for Lowering LDL-C, Lipoprotein Apheresis for Treatment of High Lipoprotein(a) to Reduce Risk of Cardiovascular Events:  The German Experience, and Targeting PAD with LDL Apheresis. The symposium will conclude with the panel of experts and audience participation of case studies about the topics discussed.

Speakers:

Patrick M. Moriarty MD, FACP, FACC serves as Director of Clinical Pharmacology, Medical Director of Atherosclerosis and LDL-Apheresis Clinic at the University of Kansas Medical Center in Kansas City.

Eliot A. Brinton, MD, FAHA, FNLA serves as President for Utah Lipid Center, Founding Board Member for the National Lipid Association, and Past President for American Board of Clinical Lipidology

Beate Jaeger, MD is a lipid specialist and director of a lipid clinic in Mulheim an der luhr, Germany who was one of several physicians appointed to lead the efforts in securing reimbursement for the treatment of Lp(a) in Germany’s Health System.

 

Dinner provided by the NLA

Hosted by Kaneka Pharma America

This event is not part of the National Lipid Association Scientific Sessions, as planned by the NLA Scientific Meetings Committee, and is not being certified for CME/CE credit.

 

Thursday, May 16 • 2:00 - 3:30pm

Location: Majestic Ballroom 5-8

A Virtual Reality in Practice View: Decreasing Cardiovascular Risk for Patients with Persistent Hypercholesterolemia

Managing elevated cholesterol despite maximally-tolerated statin therapy remains a significant challenge in dyslipidemia care. This CME satellite symposium will explore this topic through an interactive format incorporating lecture, cases, virtual reality, and audience participation. All attendees will receive Virtual Reality Goggles and headsets (for use during this symposium only) to viritually enter the heart and vessels. The learners will discuss LDL-lowering therapy in patients with persistently elevated cholesterol levels, review data on nonstatin LDL-C–lowering agents, and review best practices for managing patients with elevated LDL-C at high risk for CVD.

Speakers:

Christie M. Ballantyne, MD
Vice Chair of Research, Medicine
Professor of Medicine, Molecular and Human Genetics
Professor of Medicine, Molecular Physiology and Biophysics
Baylor College of Medicine
Director, The Maria and Alando J. Ballantyne, M.D. Atherosclerosis Clinical Research Laboratory
Co-Director, Lipid Metabolism and Atherosclerosis Clinic
Houston Methodist Hospital
Houston, TX

Michael Davidson, MD
Professor, Director of the Lipid Clinic
The University of Chicago
Pritzker School of Medicine
Chicago, IL   

Refreshments provided by Med Learning Group

Hosted by MedLearning Group

This activity is supported by educational funding provided by Sanofi Regeneron and Genzyme Corporation.


Thursday, May 16 • 7:00 - 9:00pm

Location: Royal Ballroom 2

Clinicians Live: New Opportunities to Reduce Residual Risk Beyond Statin Therapy

This 2-hour, highly interactive CME-certified symposium will feature a faculty of 5 leading international experts who will address the recent cardiovascular outcomes trials beyond LDL-C lowering with statins. The landmark REDUCE-IT trial will be examined. The intersection of lipids, inflammatory pathways, and vascular pathways in atherogenesis will be discussed in an attempt to individualize management based on risk factor assessment. This educational activity will provide the opportunity for the multidisciplinary faculty and symposium participants to work through complex issues that challenge healthcare providers in caring for patients with elevated atherogenic cholesterol and triglycerides, many (or most) of whom have been sub-optimally managed. Pre-register and learn more here

Speakers:

Sergio Fazio, MD, PhD, Chair
William and Sonja Connor Chair of Preventive Cardiology
Professor of Medicine, Physiology & Pharmacology
Director, Center for Preventive Cardiology
Knight Cardiovascular Institute
Oregon Health & Science University
Portland, OR

R. Preston Mason, PhD
Cardiovascular Division, Brigham and Women’s Hospital
Harvard Medical School
Boston, MA
Scientific Director and Founder, Elucida Research
Beverly, MA

Michael Miller, MD
Professor of Cardiovascular Medicine,
Epidemiology & Public Health
University of Maryland School of Medicine
University of Maryland Medical Center
Baltimore, MD

Margo B. Minissian, PhD, ACNP
Research Scientist
Clinical Lipid Specialist
Cardiology Nurse Practitioner
Smidt Heart Institute
Barbra Streisand Women’s Heart Center
Cedars-Sinai Medical Center
Los Angeles, CA

James A. Underberg, MD, MS
Clinical Lipidology
Clinical Assistant Professor of Medicine
NYU School of Medicine & NYU Center for
Prevention of Cardiovascular Disease
Director, Bellevue Hospital Lipid Clinic
Immediate Past President, National Lipid Association
New York, NY

 

Dinner provided by the NLA

Hosted by Medtelligence

This activity is supported by educational funding provided by Amarin Pharma Inc.


Friday, May 17 • 7:00 - 9:00am

Location: Royal Ballroom 2

Cardiovascular Risk Reduction with PCSK9 Inhibitors: Evolving Evidence, Recommendations, and Controversies - Featuring the Game On! Challenge

Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors have proven to be safe and efficacious in both current and ongoing clinical trials, but many clinicians still do not use these medications in their daily practice. In this educational activity, expert clinicians will discuss the efficacy and safety of PCSK9 inhibitors, as well as provide guidance regarding when to prescribe these medications and how to obtain them for their patients. In addition, participants will engage in Game On! - an interactive, confidence-based activity. Pre-register and learn more here

Michael H. Davidson, MD, FACC, FACP, FNLA
Professor, Director of the Lipid Clinic
The University of Chicago Pritzker School of Medicine
Chicago, IL

 

Christie M. Ballantyne, MD
Professor of Medicine
Vice Chair of Research for the Department of Medicine
Chief, Section of Cardiovascular Research

Chief, Section of Cardiology
Department of Medicine, Baylor College of Medicine
Houston, TX

 

Elizabeth Jackson, MSN, ACNS-BC, CLS, FNLA
Cardio Texas
St. David’s Medical Center
Austin, TX

 

Breakfast provided by the NLA

Hosted by Vindico Medical Education

This activity is supported by educational funding provided by Amgen. 


Friday, May 17 • 5:30 - 7:30pm

Location: Royal Ballroom 2

Beyond FH: Clinical Clues for the Diagnosis and Management of Genetic Dyslipidemias (LAL-D)

Approximately 30-40% of patients clinically diagnosed with Familial Hypercholesterolemia (FH) may not have an identified mutation in the LDLR, APOB, or PCSK9 genes. Before these patients are diagnosed with and managed for FH, it is important to consider other genetic causes of an FH-like phenotype. Join a multidisciplinary panel of experts in an interactive 2-hour symposium to review the clinical presentation, diagnosis, and management of genetic dyslipidemias beyond FH. This session will highlight Lysosomal Acid Lipase Deficiency (LAL-D) as one disease with an overlapping clinical presentation to FH. While LAL-D can look almost clinically identical to FH, the underlying cause and subsequent management are very different. The program will conclude with a live question-and-answer with our faculty panel.

Speakers:

James J. Maciejko, PhD

Donna L. Bernstein, MS, CGC

Dinner provided by the NLA

Hosted by Alexion Pharmaceuticals

This event is not part of the National Lipid Association Scientific Sessions, as planned by the NLA Scientific Meetings Committee, and is not being certified for CME/CE credit.


Saturday, May 18 • 7:00 - 8:30am

Location: Royal Ballroom 2

Novel Targeting of PCSK9 with siRNA for LDL-C Reduction in a High-Risk Population

Join us for this special CME/CE symposium over breakfast with your colleagues to learn from our experts about the future beyond monoclonal antibodies, new therapies for LDL-C lowering, clinical trial updates, and clinical implications for patients at persistent cardiovascular risk.

 

Speakers:

Nihar R. Desai, MD, MPH

Assistant Professor of Medicine (Cardiology)

Yale School of Medicine

Haven, CT

 

Robert P. Giugliano, MD

Executive Committee, FOURIER Trial

Senior Investigator, TIMI Study Group

Physician, Cardiovascular Medicine

Brigham and Women's Hospital

Associate Professor

Harvard Medical School

Boston, MA

 

Amit V. Khera, MD, MSc

Physician-scientist

Massachusetts General Hospital

Harvard Medical School

Broad Institute of MIT and Harvard

Boston, MA

 

Breakfast provided by the NLA

This activity is supported by educational funding provided by The Medicines Company.

Expert Theaters


Friday, May 17 • 11:55am - 12:55 pm

Location: Royal Ballroom 3

Lower Together: LDL-C, Risk, Hassle, Cost

Speaker:

Dr. Seth J. Baum

Hosted by Amgen


Location: Royal Ballroom 4

Praluent® (alirocumab): Introducing New Clinical Data

Speaker:

Dr. John Isaac, MD

Hosted by Sanofi-Regeneron


Saturday, May 18 • 1:15 - 2:15 pm

Location: Royal Ballroom 4

HDL Function Testing for Enhanced CVD Risk Assessment

Speaker:

Marc Penn, MD, PhD, FACC
Director of Research, Summa Cardiovascular Institute
Professor of Medicine and Integrative Medical Sciences, Skirball Laboratory of Cardiovascular
Cellular Therapeutics, Northeast Ohio Medical University
Co-Founder, Cleveland HeartLab

Presentation Overview:

  • Review of the role of advanced lipid testing in CVD risk assessment
  • Introduction of the HDL hypothesis
  • Review of the assessments of HDL functionality
  • Overview of new methods for assessing HDL function

Hosted by Quest Diagnostics-Cleveland HeartLab


Location: Royal Ballroom 3

Criticality of LDL-C Lowering: A Focus on Low LDL-C

Speaker:

Harold Edward Bays, MD, FOMA, FTOS, FACC, FACE, FNLA
Medical Director/President
Louisville Metabolic and Atherosclerosis Research Center

Hosted by Amgen

Late Breakers


Saturday, May 18
 

Effects of Icosapent Ethyl on Total Ischemic Events – Further Insights from REDUCE-IT

4:40 - 4:50 pm
Speaker: Christie Ballantyne, MD 

 

LONG TERM Twice-a-year dosing of INclisiran, A NOVEL sirna therapy, RESULTS in PERSISTENT LDL-C lowering in PHASE II EXTENSION STUDY (ORION-3)

4:50 - 5:00 pm
Speaker: John J. Kastelein, MD, PhD

 

The STatin Adverse Treatment Experience (STATE) Survey: Experience of Patients Reporting Side-Effects of Statin Therapy

5:00 - 5:10 pm
Speaker: Mary Katherine Cheeley, PharmD, BCPS, CLS

Women in Lipidology


"Life is Full" – A Dialogue About Work/Life Integration 
Hosted by Women in Lipidology
Friday, May 17

7:45-8:45pm

Join the NLA Women in Lipidology at Scientific Sessions for a special lecture from the University of Miami Miller School of Medicine's Hilit F. Mechaber, MD.

 

Hilit F. Mechaber, MD
Associate Professor of Medicine
Associate Dean for Student Services
University of Miami Miller School of Medicine
Miami, FL

 

 

Delete SPECIAL EVENTS

Edit Parent - PROGRAM (visibility Show)

AGENDA


Thursday, May 16, 2019

3:45 - 4:00 PM NLA Statement on Enhancing the Value of PCSK9 Inhibitors Jennifer G. Robinson, MD MPH
4:00 - 6:00 PM

NLA Opening Session: Utilization of Cardiometabolic Therapies for CV Risk Reduction in the Age of Precision Medicine

4:00 - 4:05 PM Introduction and Pre-Lecture Quiz Anne C. Goldberg, MD, FNLA
4:05 - 4:35 PM Current Interventions to Manage Cardiovascular Risk James A. Underberg, MD, MS, FNLA
4:35 - 4:40 PM Post-Lecture Quiz and Pre-Lecture Quiz  
4:40 - 5:10 PM New Interventions to Manage Cardiovascular Risk: Emerging Therapies and Cardiovascular Outcomes Trials Harold E. Bays, MD, FNLA
5:10 - 5:15 PM Post-Lecture Quiz and Pre-Lecture Quiz  
5:15 - 5:45 PM Case Workshop: Managing the Patient Not a Disorder Pamela B. Morris, MD, FNLA
5:45 - 5:50 PM Post-Lecture Quiz  
5:50 - 6:00 PM Q&A / Panel Discussion  
6:00 - 7:00 PM Welcome Reception in Exhibit Hall
7:00 - 9:00 PM Satellite Symposium Clinicians Live: New Opportunities to Reduce Residual Risk Beyond Statin Therapy- Medtelligence

Friday, May 17, 2019

7:00 - 9:00 AM Satellite Symposium
8:00 - 8:50 AM Breakfast in Exhibit Hall
8:55 - 9:00 AM NELA Business Meeting
9:00 - 10:45 AM Session I: So Many Guidelines- What’s a Lipidologist to Do?
9:00 - 9:05 AM Pre-Assessment Questions
9:05 - 9:25 AM Refining ASCVD Risk Assessment to Individualize Therapy in Primary Prevention Donald M. Lloyd-Jones, MD, ScM
9:25 - 9:45 AM Key Messages from the 2019 ACC/AHA Cardiovascular Disease Prevention Guidelines Salim Virani, MD, PhD
9:45 - 10:05 AM Physical Exercise Guidelines: Updates, Primary Prevention of CVD, and Exercise Prescription Beth A. Taylor, PhD, FACSM
10:05 - 10:25 AM International Perspective on 2018- 2019 Guidelines Raul D. Santos, MD, MSc, PhD
10:25 - 10:45 AM Q&A Panel & Post-Assessment Questions
10:45 - 10:50 AM Intermission
10:50 - 11:20 AM NLA Presidents' Address
11:20 - 11:25 AM W. Virgil Brown Lecture Award Presented
11:25 - 11:45 AM W. Virgil Brown Lecture Vera A. Bittner, MD, MSPH, FNLA*
11:45 - 11:55 AM Q&A
11:55 AM - 1:05 PM Lunch in Exhibit Hall
11:55 AM - 12:55 PM Expert Theaters
1:05 - 2:50 PM Session II: South Asians and Risk for ASCVD: Increasing Awareness in Medical and Non-Medical Communities
1:05 - 1:10 PM ARS
1:05 - 1:10 PM Dyslipidemia, Diabetes and ASCVD Connectome Kris Vijay, MD, FNLA*
1:30 - 1:50 PM Early Screening and Prevention Strategies Dinesh Kalra, MD
1:50 - 2:10 PM Impact of Diet and Lifestyle Modification as Primary Intervention Geeta Sikand, RDN, MA, CLS, FNLA
2:10 - 2:30 PM Opportunity to Increase Awareness Through Social Media Shoeb J. Sitafalwalla, MD
2:30 - 2:50 PM Q&A Panel & ARS
2:50 - 4:15 PM Session III: 2019 Manuscripts for the Clinical Setting
2:50 - 2:55 PM ARS
2:55 - 3:15 PM Demystifying Lipid Laboratory Measurement Alan T. Remaley, MD, PhD
3:15 - 3:35 PM Role of Genetic Testing in Clinical Lipidology and CV prevention - a primer for the busy clinician Seth S. Martin, MD, MHS
3:35 - 3:45 PM Q&A Panel & ARS  
3:45 - 4:00 PM Update on the Use of Lp(a) in the Clinical Setting Marlys L. Koschinsky. PhD, FNLA
4:00 - 4:01 PM Lp(a) NLA Paper- Introduction Don P. Wilson, MD, FNLA
4:01 - 4:06 PM Laboratory Measurement of lipoprotein(a) Marlys L. Koschinsky. PhD, FNLA
4:06 - 4:12 PM Lipoprotein(a) testing and Treatment in Clinical Practice- Primary Prevention Peter H. Jones, MD, FNLA
4:12 - 4:18 PM Lipoprotein(a) testing and Treatment in Clinical Practice- Secondary Prevention Carl E. Orringer, MD, FNLA
4:18 - 4:21 PM Lipoprotein(a) testing and Treatment in Clinical Practice- Youth Catherine J. McNeal, MD, PhD, FNLA
4:21 - 4:30 PM Q&A Panel & ARS
4:30 - 4:35 PM SWLA Business Meeting
4:35 - 4:40 PM PLA Business Meeting
5:30 - 7:30 PM Satellite Symposium
7:45 - 8:45 PM "Life is Full" - A Dialogue About Work/Life Integration - By Hilit F. Mechaber, MD Sponsored by the Women in Lipidology
7:45 - 8:45 PM New Member Event

Saturday, May 18, 2019

7:00 - 9:50 AM Satellite Symposium
8:00 - 8:50 AM Breakfast in Exhibit Hall
8:55 - 9:00 AM MWLA Business Meeting
9:00 - 9:45 AM Keynote: What do we know About Low LDL? Robert P. Giugliano, MD, SM
9:45 - 11:10 AM Session IV: MythBusters in Clinical Lipidology - Pharmacotherapy Debunked
9:45 - 9:50 AM ARS
9:50 - 10:10 AM Statin Allergy AND Statin Therapy in Type 1 Diabetes Joseph J. Saseen, PharmD, CLS, FNLA
10:30 - 10:50 AM Skin Cancer with Statins AND CoQ10 for SAMS Mark J. Cziraky, PharmD, CLS, FNLAD
10:50 - 11:10 AM Hyperglycemia and Renal Dysfunction with Lipid-Lowering Therapy Barbara S. Wiggins, PharmD, CLS, FNLA
10:50 - 11:10 AM Q&A Panel & ARS
11:10 - 11:40 AM Break in Exhibit Hall
11:40 - 12:45 AM Session V- REDUCE-IT to Practice- Debate
11:40 - 11:45 AM ARS
11:45 - 11:55 AM Triglyceride Lowering Nihar Desai, MD, MPH
11:55AM - 12:05 PM Omega-3 Fatty Acids in ASCVD Risk Reduction: An Old Fisherman's Tale or a Great Catch? Pamela B. Morris, MD, FNLA*
12:05 - 12:15 PM EPA Vera A. Bittner, MD, MSPH, FNLA*
12:15 - 12:25 PM Is it the Dose? Donald M. Lloyd-Jones, MD, ScM
12:25 - 12:45 PM Q&A Panel & ARS
12:45 - 1:15 PM NLA and SELA Business Meeting and Poster Winners Announced, Foundation of the NLA Update
1:15 - 2:15 PM Lunch in Exhibit Hall
1:15 - 2:15 PM Expert Theater
TRACK 1
2:15 - 4:00 PM Session VI: Women’s Health Session
2:15 - 2:20 PM ARS
2:20 - 2:40 PM Selection of Contraceptive Therapy in the Dyslipidemic Patient Melissa F. Wellons, MD
2:40 - 2:50 PM Young Investigator Winner
2:50 - 3:10 PM Update in Postmenopausal Hormone Replacement Therapy Ekta Kapoor, MBBS
3:10 - 3:20 PM Donald Hunninghake, MD, Familial Hypercholesterolemia Abstract Award Winner Presentation
3:20 - 3:40 PM Is the Diagnosis of Polycystic Ovary Syndrome Important in Adolescents? Anuja Dokras, MD, PhD
3:40 - 4:00 PM Q&A Panel & ARS
TRACK 2
2:15 - 3:45 PM Session VII: Clinical Pearls
2:15 - 2:30 PM ARS
2:20 - 2:30 PM Oral Poster Winner
2:30 - 2:50 PM Managing ASCVD Risk in Diabetes: How do I choose--SGLT2 inhibitor or GLP-RA? Valentina Rodriguez, MD
2:50 - 3:00 PM Oral Poster Winner
3:00 - 3:20 PM Nutraceuticals in Statin Intolerance Maciej Banach, MD, PhD, FNLA
3:20 - 3:30 PM Oral Poster Winner
3:30 - 3:45 PM Q&A Panel & ARS
4:00 - 4:05 PM Break
4:05 - 4:35 PM Special Session: Junior Faculty Research Award Presentations
4:05 - 4:15 PM Genome Interpretation for Risk of Heart Attack Amit V. Khera, MD, MSc
4:05 - 4:15 PM Mechanisms of Lipoprotein Lipase Folding Saskia Neher, PhD
4:25 - 4:35 PM Q&A Panel
4:35 - 4:40 PM Break
4:40 - 5:10 PM Late Breakers
5:15 - 5:45 PM VIP Fellows of the NLA Only Reception
5:45 - 7:15 PM Honors and Awards Ceremony
7:30 - 10:30 PM NLA Foundation Event

Sunday, May 19, 2019

7:00 - 8:00 AM Breakfast
8:00 - 9:45 AM Session VIII: Heart Healthy Eating and Cultural Differences
8:00 - 8:05 AM ARS
8:05 - 8:25 AM Southern diet Ginnie Barringer, MS LDN CDE BCADM
8:25 - 8:45 AM Latino/Hispanic diet Heather E. Rasmussen, PhD, RDN
8:45 - 9:05 AM South Asian Diet: Heart Healthy Eating and Cultural Considerations Wahida Karmally, PhD, DrPH, RDN, CDE, CLS, FNLA
9:05 - 9:25 AM A Mediterranean Style Eating Pattern  Mary N. Felando, MS, RDN, FNLA
9:25 - 9:45 AM Q&A Panel & ARS
9:45 - 9:55 AM Break
9:55 - 11:40 AM Session IX: Top Three Countdown
9:55 - 10:00 AM ARS
10:00 - 10:20 AM Top 3 Potentially Practice-Changing Clinical Trials Antonio M. Gotto, Jr., MD, DPhil, FNLA*
10:20 - 10:40 AM Top 3 Publications on Novel Mechanisms of Lipid Lowering Harold E. Bays, MD, FNLA*
10:40 - 11:00 AM Top 3 Gaps in Knowledge in Management of Dyslipidemia Kim K. Birtcher, PharmD, CLS, FNLA
11:00 - 11:20 AM Top 3 Publications in JCL 2018-2019 John R. Guyton, MD, FNLA*
11:20 - 11:40 AM Q&A Panel & ARS
11:40 AM Adjourn

ACCREDITATION


Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 16.25 AMA PRA Category 1 Credits™ MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

In support of improving patient care, this activity has been planned and implemented by The National Lipid Association. The National Lipid Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Physician Credit Designation Statement
The National Lipid Association designates this live activity for a maximum of 16.25 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in this activity.

Physician Assistants
NCCPA accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.

Dietitians
The National Lipid Association is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 16.00 continuing professional education units (CPEUs) for completion of this program/ materials. CDR Accredited Provider #NL002.

Pharmacist Accreditation Statement

Universal Activity Number JA0007192-0000-19-001-L01-P (Application)

This Activity has been approved for 16.25 contact hour(s) (1.625 CEUs) of the Accreditation Council for Pharmacy Education

 

Nursing
The maximum number of hours awarded for this CE activity is 16.3 contact hours.

Pharmacotherapy contact hours for Advance Practice Registered Nurses to be determined.

EDUCATION OVERVIEW


Target Audience
This activity is designed to meet the needs of physicians, physician assistants, pharmacists, registered nurses, nurse practitioners, advance practice registered nurses, and registered dietitians with an interest in lipid management.

Type of Activity
Live Activity
Application

 

Educational Objectives

At the conclusion of this activity, all participants should be able to:

  • Discuss strategies to improve the knowledge, skills or performance of the healthcare team;

Session I: So Many Guidelines- What’s a Lipidologist to Do?

  • Review the 2018 cholesterol guidelines for the diagnosis, management and treatment of at-risk patients.
  • Evaluate the clinical implications of the 2018 physical exercise guidelines.
  • Compare the international guidelines for the management of dyslipidemia.

W. Virgil Brown Lecture

  • Evaluate the management of patients with dyslipidemia.

Session II: South Asians and risk for ASCVD:  Increasing Awareness in Medical and Non-Medical Community

  • Recognize the risk factors and interconnection of early onset diabetes and CAD in South Asians.
  • Discuss practical strategies for diet and physical activity interventions in South Asians.
  • Describe the role of social media in disease awareness and patient education. 

Session III: 2019 Manuscripts

  • Explain the issues related to accurate measurement of lipids and lipoproteins in laboratory testing.
  • Recognize the potential of genetic testing in clinical practice.
  • Discuss the clinical recommendations for measuring Lipoprotein(a) (Lp(a)) to manage dyslipidemia and risk.

Saturday Morning Keynote

  • Determine potential health risks and benefits associated with low LDL.

Session IV: MythBusters in Clinical Lipidology- Pharmacotherapy Debunked

  • Analyze common misconceptions regarding pharmacotherapy in the management of patients with dyslipidemia.

Session V: REDUCE-IT to Practice

  • Interpret the evidence and clinical implications of recent outcomes trials of omega-3 fatty acids.

Session VI: Women’s Health Sessions

  • Identify the appropriate contraceptive options for patients with dyslipidemia.
  • Critically appraise emerging research and its applications to daily clinical practice.
  • Explain the impact that hormone replacement therapy can have on postmenopausal patients.
  • Discuss the risks associated with Polycystic ovary syndrome (PCOS) and its potential impact on metabolic disease.

Session VII: Clinical Pearls

  • Critically appraise emerging research and its applications to daily clinical practice.
  • Compare therapeutic options for the treatment of diabetes. 
  • Explore evidence for the management of statin intolerance through the use of nutraceuticals.

Special Session: Junior Faculty Research Award Presentations

  • Discuss the recent research impacting future management of patients with dyslipidemia.

Session VIII: Heart Healthy Eating and Cultural Differences 

  • Identify the impact of specific diet patterns for the management of dyslipidemia.

Session IX: Top Three Countdown

  • Discuss the implications of lipid treatment outcomes trials for the clinical management of patients with dyslipidemia.
  • Review the publications of new lipid therapies and the application to the management of patients with dyslipidemia.
  • Identify gaps in the management of dyslipidemia.
  • Review the practical application of recent publications to the clinical evaluation and management of patients with dyslipidemia.

Ancillary Courses


Are you new to Lipidology or just looking to brush up on the changing information coming out in the field? Attend one of our ancillary courses taught by Experts in the area of Lipidology:

The NLA's Masters in Lipidology course provides an advanced examination of the core curriculum in Clinical Lipidology. This course is designed for any health care professional with experience in Lipidology who desires advanced training. Experts in the field of Lipidology will lecture on advanced concepts and guide participants through interactive learning scenarios that provide tools and skills to further advance personal standards of practice. It is recommended that attendees have already completed preparatory coursework (eg Foundations of Lipidology [formerly Lipid Academy] or similar core curriculum training).

The NLA's Foundations of Lipidology course, formerly Lipid Academy, provides an introductory review of the core curriculum in Clinical Lipidology. This course is designed for any healthcare professional seeking to learn the fundamentals of Lipidology. Experts in Lipidology will lecture on basic concepts and guide participants through interactive learning scenarios that provide the knowledge and tools necessary to work effectively in a lipid practice, and prepare for advanced training.

Delete PROGRAM

Edit Parent - VENUE (visibility Show)

Venue Information


Turnberry Isle Miami

19999 W. Country Club Dr.
Aventura, FL 33180


Meeting Room Rate: $229/night plus tax

More about the venue

Visit South Florida


 

Arts & Culture

Attractions

Beaches

Restaurants

Health & Fitness

History & Heritage

Nightlife

Shopping

Sports

Tours & Excursions

Parks & Recreation

Water Activities

 

Images courtesy of Greater Miami Convention & Visitors Bureau. For more information, visit miamiandbeaches.com.

Delete VENUE

Edit Parent - ENGAGE (visibility Show)

Social Media


Be part of the conversation and get the latest news and announcements from Scientific Sessions. Follow the NLA on Twitter, Instagram, LinkedIn, and Facebook. Use the hashtag #NLASessions when posting about the meeting.

Connect With Exhibitors


Aegerion Pharmaceuticals
www.novelion.com/about-novelion/aegerion-pharmaceuticals

Alexion Pharmaceuticals
www.Alexion.com

Amarin Pharma, Inc.
www.amaincorp.com

Ambry Genetics, A Konica Minolta Company
www.ambrygen.com

Amgen Inc.
www.amgen.com

Boston Heart Diagnostics
www.bostonheartdiagnostics.com

Carlson Laboratories
www.carlsonlabs.com

Denka Seiken Co., Ltd
www.denka-seiken.jp

Familial Chylomicronemia Syndrome (FCS) Foundation
www.LivingWithFCS.org

Invitae
www.invitae.com 

Kaneka Pharma America
www.kaneka.co.jp

Medicure Pharma, Inc.
www.medicure.com

MotherToBaby
www.mothertobaby.org

Phosphorus
www.phosphorus.com

Piper Biosciences
www.piperbio.com

Quest Diagnostics - Cleveland HeartLab CardioMetabolic Center of Excellence
www.clevelandheartlab.com

Retrophin Inc.
www.retrophin.com

Sanofi Regeneron 
www.Sanofi.us

www.regeneron.com

Media Partners


Step Challenge


Compete with your peers to take the most steps during your time in Miami!

The NLA Step Challenge starts on Thursday, May 16 at 3:00 p.m. ET and ends on Saturday, May 18 at 11:00 a.m. ET.

FREE Bluetooth activity trackers will be given out to the first 100 participants who check in with the Step Challenge staff at the NLA Registration desk. You can also use your own tracking devices to join. 

STEP GOAL PRIZES FROM THE NLA

  • 25K Stepper Prize Drawing:  all participants that exceed 25K steps during the Challenge will be entered into a drawing for a free hotel night at JW Marriott Turnberry Miami (during the 2019 Scientific Sessions) and a Yeti Rambler 14 oz, Stainless Steel Vacuum Insulated Mug.​
  • Top Stepper Prize:  the top stepper on the final Leaderboard will win a free hotel night at JW Marriott Turnberry Miami (during the 2019 Scientific Sessions) AND a Yeti Hopper Backflip Cooler.

Want to boost your steps?

Visit the following locations during the conference to gain 150 extra steps!

  • Amgen Expert Theater on Friday, May 17th at 11:55am – 12:55pm
  • Amgen Exhibit Booth (Booth #101 in the NLA Exhibit Hall)
  • Young Investigator Award Winning Abstract (#308 in e-Poster Hall)
  • Hunninghake Award Winning Abstract (#280 in e-Poster Hall)

Also, visit the Amgen Booth (in Exhibit Hall) on Friday, May 17 for a chance to win a giveaway of a $100 Amazon Gift Card from the NLA.

 

Visit our Step Challenge Webpage to learn more, pre-register for the challenge, and to download our Step Challenge tracker mobile app. 

Step Challenge is sponsored by Amgen Inc. 

Delete ENGAGE

Edit Parent - SUPPORT (visibility Show)

Exhibit in Miami


It is our pleasure to invite you to join us as an exhibitor at the 2019 Scientific Sessions. NLA meetings provide you with an opportunity to reach your target audience of Lipidologists, Cardiologists, Endocrinologists, Primary Care Physicians, PhD researchers, and clinical team affiliates, from an array of disciplines including nurses, nurse practitioners, physician assistants, pharmacists, exercise physiologists, and dietitians, in a uniquely intimate educational setting. We are proud to showcase not only an agenda led by distinguished faculty who are leaders in their fields, but a lively exhibit hall to act as a home-base for our attendees. On behalf of our board of directors and the members we serve, we look forward to seeing you in 2019.

 

Host A Symposium


The NLA has established that independently developed CME/CE-certified satellite symposia held in conjunction with the scientific meetings of the NLA are valuable opportunities to provide continuing education for our members and meeting participants.

In this regard, we are pleased to offer satellite symposia opportunities in conjunction with our 2019 Scientific Sessions. Satellite symposia curriculum should include educational topics that complement or supplement the Scientific Sessions program agenda, addressing educational gaps preventing optimal patient care. Download our guidelines to view important information regarding hosting a satellite symposium, including the proposal creation and application processes.

Please contact the NLA Program Development department directly should you have any questions or require additional information. We hope to see you in Miami!

Interested in non-CME programming? Please email exhibits@lipid.org

DOWNLOAD SYMPOSIA GUIDELINES
AND APPLICATION

Delete SUPPORT


SCIENTIFIC MEETINGS CO-CHAIRS

Alan S. Brown, MD, FNLA

Committee Co-Chair
President, National Lipid Association
Director, Division of Cardiology

Advocate Lutheran General Hospital
Co-Director, Cardiology Service Line
Advocate Medical Group
Clinical Associate Professor
Loyola Stritch School of Medicine
Park Ridge, IL

Anne C. Goldberg, MD, FACP, FNLA

Committee Co-Chair
President, Foundation of the NLA

Professor of Medicine
Washington University School of Medicine
St. Louis, MO



PROGRAM PLANNERS

Sergio Fazio, MD, PhD, FNLA

Program Planner
William and Sonja Connor Chair of Preventive Cardiology
Professor of Medicine
Director of Preventive Cardiology
Knight Cardiovascular Institute
Oregon Health and Science University
Portland, OR

Edward A. Gill, MD, FNLA

Program Planner
Director of Interventional Echocardiography
Professor of Medicine
Division of Cardiology
University of Colorado School of Medicine, Anschutz
Aurora, CO

Antonio M. Gotto, MD, DPhil, FNLA

Program Planner
President-Elect, National Lipid Association

Dean Emeritus
Weill Cornell Medicine
New York, NY

Elizabeth Jackson, MSN, ACNS-BC, CLS, FNLA

Program Planner
Cardio Texas
St. David's Medical Center
Austin, TX

Peter H. Jones, MD, FNLA

Program Planner
Director, Division of Cardiology
Associate Professor of Medicine Co-director, 
Lipid Metabolism and Atherosclerosis Clinic Center for
Cardiovascular Disease Prevention
Houston Methodist DeBakey Heart and Vascular Center 
Baylor College of Medicine 
Houston, TX

Carol Kirkpatrick, PhD, RDN, MPH, CLS, FNLA

Program Planner
Wellness Center Director
Clinical Assistant Professor
Idaho State University
Pocatello, ID

 

Pamela B. Morris, MD, FNLA

Program Planner
President, Southeast Lipid Association

Director, Preventive Cardiology
Co-Director, Women’s Heart Care
Medical University of South Carolina
Charleston, SC

Carl E. Orringer, MD, FNLA

Associate Professor of Medicine
University of Miami
School of Medicine
Miami, FL

Joseph J. Saseen, PharmD, CLS, FNLA

Program Planner
Secretary/Treasurer, National Lipid Association

Professor and Vice Chair
Department of Clinical Pharmacy
Professor, Department of Family Medicine
University of Colorado
Anschutz Medical Campus
Aurora, CO

Daniel E. Soffer, MD, FNLA

Program Planner
President, Northeast Lipid Association

University of Pennsylvania Health System
Internal Medicine/Clinical Lipidology
Perelman Center for Advanced Medicine
Philadelphia, PA



FACULTY

Prof. Maciej Banach, MD, PhD, FNLA

Polish Mother’s Memorial Hospital Research Institute (PMMHRI)
Lodz, Poland

Harold E. Bays, MD, FNLA

Medical Director/President
Louisville Metabolic and Atherosclerosis Research Center
Louisville, KY

Kim K. Birtcher, PharmD, CLS, FNLA

Clinical Professor
University of Houston College of Pharmacy
Houston, TX

Vera A. Bittner, MD, MSPH, FNLA

Professor of Medicine
Section Head, General Cardiology,
Prevention and Imaging
University of Alabama at Birmingham
Birmingham, AL

Mark J. Cziraky, PharmD, CLS, FNLA

Vice President of Research
HealthCore Inc.
Wilmington, DE

Nihar R. Desai, MD, MPH

Assistant Professor of Medicine (Cardiology)
Yale School of Medicine
Haven, CT

Anuja Dokras, MD, PhD

Professor of Obstetrics and Gynecology
Director, PENN PCOS Center
Medical Director, HUP Reproductive Surgical Facility
The Perelman School of Medicine
University of Pennsylvania
Philadelphia, PA

Mary N. Felando, MS, RDN, FNLA

Nutrition Consultant
Seal Beach, CA

Robert P. Giugliano, MD, SM

Executive Committee, FOURIER Trial
Senior Investigator, TIMI Study Group
Physician, Cardiovascular Medicine
Brigham and Women's Hospital
Associate Professor
Harvard Medical School
Boston, MA

Antonio M. Gotto, MD, DPhil, FNLA

Program Planner
President-Elect, National Lipid Association

Dean Emeritus
Weill Cornell Medicine
New York, NY

John R. Guyton, MD, FNLA

Professor of Medicine
Assistant Professor of Pathology
Department of Medicine
Duke University School of Medicine
Durham, NC

Dinesh Kalra, MD

Director
Advanced Cardiac Imaging
Rush University Medical Center
Chicago, IL

Ekta Kapoor, MBBS, FACP

Assistant Professor of Medicine
Women’s Health Clinic (Division of General Internal Medicine)
Division of Endocrinology, Metabolism and Nutrition
Mayo Clinic
Rochester, MN

Wahida Karmally, PhD, DrPH, RDN, CDE, CLS, FNLA

Special Research Scientist
Columbia University
Research Chair
Diabetes Care and Education
Academy of Nutrition and Dietetics
Fort Lee, NJ

Amit V. Khera, MD, MSc

Physician-scientist
Massachusetts General Hospital
Harvard Medical School
Broad Institute of MIT and Harvard
Boston, MA

Marlys L. Koschinsky, PhD

Scientific & Executive Director
Robarts Research Institute
Schulich School of Medicine & Dentistry
Western University
London, ON, Canada

Donald M. Lloyd-Jones, MD, ScM

Senior Associate Dean for Clinical and Translational Research
Chair, Department of Preventive Medicine
Director, Northwestern University Clinical and Translational Sciences Institute (NUCATS)
Eileen M. Foell Professor
Professor, Preventative Medicine (Epidemiology) and Medicine (Cardiology)
Chicago, IL

Seth S. Martin, MD, MHS

Assistant Professor of Medicine
Division of Cardiology
Department of Medicine
Johns Hopkins University School of Medicine
Director, Advanced Lipid Disorders Program Ciccarone Center for
 the Prevention of Cardiovascular Disease
Baltimore, MD

Pamela B. Morris, MD, FNLA

Program Planner
President, Southeast Lipid Association

Director, Preventive Cardiology
Co-Director, Women’s Heart Care
Medical University of South Carolina
Charleston, SC

Saskia Neher, PhD

Assistant Professor
Department of Biochemistry and Biophysics
University of North Carolina at Chapel Hill
Chapel Hill, NC

Heather E. Rasmussen, PhD, RDN

Assistant Professor
University of Nebraska- Lincoln
Lincoln, NE

Alan T. Remaley, MD, PhD

Section Chief Lipoprotein Metabolism Laboratory
National Heart, Lung, and Blood Institute
National Institutes of Health
Bethesda, MD

Valentina Rodriguez, MD

Assistant Professor of Medicine
Division of Endocrinology, Diabetes, and Metabolism
University of Miami Miller School of Medicine
Miami, FL

Raul D. Santos, MD, MSc, PhD

President, International Atherosclerosis Society
Associate Professor and Director
Lipid Clinic Heart Institute (InCor)
University of São Paulo Medical School
Hospital São Paulo- Brazil
Scientific Advisor Preventive Medicine
Center Hospital Israelita Albert Einstein
São Paulo, Brazil

Joseph J. Saseen, PharmD, CLS, FNLA

Program Planner
Secretary/Treasurer, National Lipid Association

Professor and Vice Chair
Department of Clinical Pharmacy
Professor, Department of Family Medicine
University of Colorado
Anschutz Medical Campus
Aurora, CO

Geeta Sikand, RDN, MA, CLS, FNLA

Director of Nutrition Preventive Cardiology Program
Associate Clinical Professor of Medicine
University of California Irvine School of Medicine
Irvine, CA

Shoeb J. Sitafalwalla, MD

Advocate Health Care
Advocate Lutheran General Hospital
Park Ridge, IL

Beth A. Taylor, PhD, FACSM

Associate Professor, Kinesiology
University of Connecticut
Director, Exercise Physiology Research
Hartford Hospital
Storrs, CT

Kris Vijay, MD, FNLA

Medical Director, CHF Program
Abrazo Health Network and Arizona Heart Hospital
Phoenix, AZ

Salim S. Virani, MD, PhD

Assistant Professor
Medicine-Atherosclerosis & Lipoprotein
Medicine - Cardiology
Baylor College of Medicine
Houston, TX

Melissa F. Wellons, MD

Associate Professor of Medicine
Division of Diabetes, Endocrinology, and Metabolism
Department of Medicine
Vanderbilt University Medical Center
Nashville, TN

Barbara S. Wiggins, PharmD, CLS, FNLA

Pharmacy Clinical Specialist- Cardiology
Medical University of South Carolina
Charleston, SC



Register for 2019 Scientific Sessions

Registration Options






NLA Member Pricing
*Must be logged in


Main Session

May 16-19, 2019


Masters in Lipidology

May 15-16, 2019


Foundations of Lipidology

May 15-16, 2019



Add-ons


Guest Ticket

May 16, 2019


Non-Member Pricing


Main Session

May 16-19, 2019

OR

Join the NLA and save on registration

$195.00 NLA Member Applicaton + $695.00 Main Session Registration - $50.00 New Member Discount

Masters in Lipidology

May 15-16, 2019


Foundations of Lipidology

May 15-16, 2019



Add-ons


Guest Ticket

May 16, 2019


Trainee Pricing
*Must be logged in


Main Session

May 16-19, 2019


Masters in Lipidology

May 15-16, 2019


Foundations of Lipidology

May 15-16, 2019

$ 0.00



Add-ons


Guest Ticket

May 16, 2019


Interested in the Trainee Rate?


Enrolled in a graduate or postgraduate training program and want to attend at the Trainee Member rate?

Apply now for free





Disclaimer


Lipid Bucks: Lipid Bucks can be applied on the checkout page.

Registration: Online registration and payment must be received no later than May 19, 2019. After this date, meeting materials and name badge cannot be guaranteed, but onsite registration will be available until May 19, 2019. By registering for this meeting, attendee understands and agrees that attendee’s name, city, and state may be shared with other attendees and exhibitors. By allowing an exhibitor to scan the conference badge, attendee understands, agrees and consents to the sharing of attendee’s contact information with the company that scanned the conference badge.

Cancellation: Telephone cancellations will not be accepted. A written notice of cancellation must be received no later than . This includes social events and guest fees. There will be a $100 fee for all cancellations. There will be no refunds if cancelling within 30 days of the start of the meeting date.

Attendees who need special reasonable accommodations or who have special needs should contact the meeting organizers at 904-998-0854.